96. Crohn disease Clinical trials / Disease details

Clinical trials : 2,400 / Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02538354 (ClinicalTrials.gov)	March 2016	20/8/2015	The Effect of Riboflavin in Crohn's Disease	The Effect of Riboflavin Supplementation on Faecalibacterium Prausnitzii in Crohn's Disease	Crohn Disease	Dietary Supplement: Riboflavin supplementation	University Medical Center Groningen	NULL	Completed	18 Years	65 Years	All	70	N/A	Netherlands
2	NCT02769494 (ClinicalTrials.gov)	March 2016	9/3/2016	The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer	The Efficacy of Topically Applied Mesalazine Sustained-Release Tablets in Oral Lesions of Crohn's Disease	Crohn's Disease;Oral Ulcer	Drug: Mesalazine Sustained-Release Tablets;Drug: Riboflavin Sodium Phosphate Injection	Xijing Hospital of Digestive Diseases	NULL	Recruiting	18 Years	65 Years	Both	40	Phase 3	China